Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

215ON201 BIIB033 In Acute Optic Neuritis (AON) (RENEW)
Place of birth, age of immigration, and disability in Hispanics with multiple sclerosis.
Δ⁹-tetrahydrocannabinol (Δ⁹-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease.
Genes associated with T helper 17 cell differentiation and function.
“Veterinary Medicines” page
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
Multiple sclerosis, vitamin D, and HLA-DRB1*15.
Avonex approval application
Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice.
Adeona Announces Completion of Planned Enrollment in Phase II Multiple Sclerosis Clinical Trial
Understanding the Metabolic Consequences of Human Arylsulfatase A Deficiency through a Computational Systems Biology Study.
Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice.
Delta-9-tetrahydrocannabinol/cannabidiol (sativex(®)): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.
Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence.
Estrogen and testosterone therapies in multiple sclerosis.
Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study.
A study comparing the effectiveness and safety of teriflunomide and interferon beta-1a in patients with relapsing multiple sclerosis (TENERE)
Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study.
Tumor necrosis factor alpha but not interleukin 1 beta mediates neuroprotection in response to acute nitric oxide excitotoxicity.
A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases.
UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model.
Teva announces U.S. FDA approval of three-times-a-week COPAXONE® (glatiramer acetate injection) 40mg/mL
The value of qualitative and quantitative assessment of lesion to cerebral cortex signal ratio on double inversion recovery sequence in the differentiation of demyelinating plaques from non-specific T2 hyperintensities.
Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort.

Pages